Accounts Receivable, after Allowance for Credit Loss, Current of HUTCHMED (China) Ltd from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
HUTCHMED (China) Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • HUTCHMED (China) Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $126,750,000, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

HUTCHMED (China) Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $126,750,000 -$28,787,000 -19% 31 Dec 2025 20-F 05 Mar 2026 2025 FY
Q2 2025 $146,967,000 -$9,949,000 -6.3% 30 Jun 2025 6-K 07 Aug 2025 2025 Q2
Q4 2024 $155,537,000 +$38,643,000 +33% 31 Dec 2024 20-F 05 Mar 2026 2025 FY
Q2 2024 $156,916,000 +$27,713,000 +21% 30 Jun 2024 6-K 31 Jul 2024 2024 Q2
Q4 2023 $116,894,000 +$18,906,000 +19% 31 Dec 2023 20-F 19 Mar 2025 2024 FY
Q2 2023 $129,203,000 +$52,125,000 +68% 30 Jun 2023 6-K 31 Jul 2023 2023 Q2
Q4 2022 $97,988,000 +$14,408,000 +17% 31 Dec 2022 20-F 28 Feb 2024 2023 FY
Q2 2022 $77,078,000 +$19,125,000 +33% 30 Jun 2022 6-K 01 Aug 2022 2022 Q2
Q4 2021 $83,580,000 +$35,710,000 +75% 31 Dec 2021 20-F 28 Feb 2023 2022 FY
Q2 2021 $57,953,000 +$13,330,000 +30% 30 Jun 2021 6-K 28 Jul 2021 2021 Q2
Q4 2020 $47,870,000 +$6,460,000 +16% 31 Dec 2020 20-F 03 Mar 2022 2021 FY
Q2 2020 $44,623,000 +$1,865,000 +4.4% 30 Jun 2020 6-K 30 Jul 2020 2020 Q2
Q4 2019 $41,410,000 +$1,234,000 +3.1% 31 Dec 2019 20-F 04 Mar 2021 2020 FY
Q3 2019 $40,332,000 30 Sep 2019 6-K 21 Jan 2020 2019 Q3
Q2 2019 $42,758,000 -$1,661,000 -3.7% 30 Jun 2019 6-K 30 Jul 2019 2019 Q2
Q1 2019 $42,273,000 31 Mar 2019 6-K 06 Jun 2019 2019 Q1
Q4 2018 $40,176,000 +$1,766,000 +4.6% 31 Dec 2018 20-F 03 Mar 2020 2019 FY
Q2 2018 $44,419,000 +$907,000 +2.1% 30 Jun 2018 6-K 27 Jul 2018 2018 H1
Q4 2017 $38,410,000 -$2,402,000 -5.9% 31 Dec 2017 20-F 11 Mar 2019 2018 FY
Q2 2017 $43,512,000 30 Jun 2017 6-K 31 Jul 2017 2017 Q2
Q4 2016 $40,812,000 +$7,466,000 +22% 31 Dec 2016 20-F 12 Mar 2018 2017 FY
Q4 2015 $33,346,000 31 Dec 2015 20-F 13 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.